PE20011332A1 - Ensayo inmunologico y reactivo para diagnostico de malaria - Google Patents

Ensayo inmunologico y reactivo para diagnostico de malaria

Info

Publication number
PE20011332A1
PE20011332A1 PE2001000179A PE2001000179A PE20011332A1 PE 20011332 A1 PE20011332 A1 PE 20011332A1 PE 2001000179 A PE2001000179 A PE 2001000179A PE 2001000179 A PE2001000179 A PE 2001000179A PE 20011332 A1 PE20011332 A1 PE 20011332A1
Authority
PE
Peru
Prior art keywords
immunological
malaria
diagnosis
malt
refers
Prior art date
Application number
PE2001000179A
Other languages
English (en)
Inventor
Kook-Jin Lim
Mi-Jin Shon
Seung-Bum Yoo
Sang-Ik Lee
Jae-Hoon Oh
Seung-Won Lee
Hyung-Cheol Kim
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR20000007650A external-priority patent/KR100482190B1/ko
Priority claimed from KR10-2000-0007649A external-priority patent/KR100400666B1/ko
Priority claimed from KR10-2000-0012172A external-priority patent/KR100373918B1/ko
Priority claimed from KR10-2000-0045806A external-priority patent/KR100427513B1/ko
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of PE20011332A1 publication Critical patent/PE20011332A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/445—Plasmodium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE REFIERE A UN ENSAYO INMUNOLOGICO INDIRECTO (DE CAPTURA DE IgM O INMUNOLOGICO ENZIMATICO) Y A UN REACTIVO DE DIAGNOSTICO PARA MALARIA LOS CUALES DETECTAN ANTICUERPOS ESPECIFICOS EN SANGRE IgM, IgG MEDIANTE EL USO DE ANTIGENOS DE PROTOZOARIOS DE MALARIA, ANTIGENO SUPERFICIAL DEL PROTOZOARIO DE MALARIA. TAMBIEN SE REFIERE A UN METODO PARA PREPARAR PROTEINA SUPERFICIAL DEL MEROZOITO DE PLASMODIUM VIVAX QUE ES EL TODO O PARTE DEL POLIPEPTIDO PV200C DE 108 AMINOACIDOS; MEDIANTE EL USO DE LEVADURAS DE E.COLI TRANSFORMANTE
PE2001000179A 2000-02-17 2001-02-16 Ensayo inmunologico y reactivo para diagnostico de malaria PE20011332A1 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20000007648 2000-02-17
KR20000007650A KR100482190B1 (ko) 2000-02-17 2000-02-17 대장균을 이용한 삼일열 말라리아 원충의 표면 단백질의 제조방법
KR10-2000-0007649A KR100400666B1 (ko) 2000-02-17 2000-02-17 효모를 이용한 삼일열 말라리아 원충 표면 단백질의제조방법
KR10-2000-0012172A KR100373918B1 (ko) 2000-02-17 2000-03-10 말라리아의 효소 면역학적 측정방법 및 이에 사용되는진단시약
KR10-2000-0045806A KR100427513B1 (ko) 2000-02-17 2000-08-08 말라리아 특이 면역글로블린 엠의 검출에 의한 말라리아의면역학적 측정방법, 진단시약 및 진단방법

Publications (1)

Publication Number Publication Date
PE20011332A1 true PE20011332A1 (es) 2002-01-24

Family

ID=27532341

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000179A PE20011332A1 (es) 2000-02-17 2001-02-16 Ensayo inmunologico y reactivo para diagnostico de malaria

Country Status (9)

Country Link
US (1) US20040132117A1 (es)
EP (1) EP1255852B9 (es)
CN (1) CN1406284A (es)
AR (1) AR027370A1 (es)
AT (1) ATE417124T1 (es)
AU (1) AU2001236141A1 (es)
DE (1) DE60136911D1 (es)
PE (1) PE20011332A1 (es)
WO (1) WO2001061032A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100427513B1 (ko) * 2000-02-17 2004-04-30 주식회사 엘지생명과학 말라리아 특이 면역글로블린 엠의 검출에 의한 말라리아의면역학적 측정방법, 진단시약 및 진단방법
KR100373918B1 (ko) * 2000-02-17 2003-02-26 주식회사 엘지생명과학 말라리아의 효소 면역학적 측정방법 및 이에 사용되는진단시약
DE10161051B4 (de) * 2001-12-12 2005-09-15 Wieland, Heinrich, Prof. Dr. Diagnose der Malaria
KR101035111B1 (ko) * 2004-06-30 2011-05-19 주식회사 엘지생명과학 말라리아 플라스모듐 팔시파룸의 면역학적 측정방법 및이에 사용되는 측정 수단
US20080080302A1 (en) * 2006-09-29 2008-04-03 Fujifilm Corporation Droplet mixing method and apparatus
KR100968848B1 (ko) * 2007-12-13 2010-07-09 주식회사 바이오랜드 삼일열 및 열대열 말라리아 젖산탈수소효소에 특이적인항체 및 이를 포함하는 열대열 말라리아와 삼일열말라리아의 중복 감염 진단 키트
AP2012006517A0 (en) * 2010-03-23 2012-10-31 Univ Michigan State Histidine rich protein-2 diagnostic test for cerebral malaria
CN102981002B (zh) * 2012-11-29 2014-08-06 同昕生物技术（北京）有限公司 采用标签蛋白人源化嵌合抗体作为阳性对照物的间接免疫检测方法及试剂盒
CN103965313B (zh) * 2013-01-28 2016-04-13 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CN103965324B (zh) * 2013-01-29 2016-08-10 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CN113406045B (zh) * 2020-03-16 2022-11-04 广州创瑞健康科技有限公司 一种疟原虫检测的荧光染色方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304371A (en) * 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
JP2000504223A (ja) * 1996-01-29 2000-04-11 ジョージタウン・ユニヴァーシティ Ｍｓａ１ペブチドの付加に基づいたマラリアワクチン
FR2744724B1 (fr) * 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
DE19723463A1 (de) * 1997-06-04 1998-12-10 Dade Behring Marburg Gmbh Immunchemische Bestimmung von multivalenten Analyten

Also Published As

Publication number Publication date
WO2001061032A1 (en) 2001-08-23
EP1255852A4 (en) 2004-12-29
AR027370A1 (es) 2003-03-26
EP1255852B1 (en) 2008-12-10
EP1255852A1 (en) 2002-11-13
AU2001236141A1 (en) 2001-08-27
EP1255852B9 (en) 2009-04-15
CN1406284A (zh) 2003-03-26
US20040132117A1 (en) 2004-07-08
ATE417124T1 (de) 2008-12-15
DE60136911D1 (de) 2009-01-22

Similar Documents

Publication Publication Date Title
PE20011332A1 (es) Ensayo inmunologico y reactivo para diagnostico de malaria
EP1264890A3 (en) Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
HK1089232A1 (en) Use of a midregional proadrenomedullin partial peptide in biological fluids in the production of immological diagnostic agents
ES2064316T3 (es) Composicion de peptido y procedimiento para la deteccion de anticuerpos frente al htlv-iii.
ES2129630T3 (es) Diagnosis de leishmaniosis.
DK0570489T3 (da) Leverstadium-specifikke peptidsekvenser af P.falciparum, der bærer epitoper, som er i stand til at stimulere T-lymfocytter
EP1104887A3 (en) A method and test kit for assaying collagen fragments in body fluids
HUP0303134A2 (hu) HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és eljárás HIV által indukált antitestek detektálására
DE50304608D1 (de) Sandwich-immunoassay zur bestimmung von proanp-teilpeptiden
SE0000675D0 (sv) Monoclonal antibodies
EP0869177A3 (en) Human a- and b- platelet-derived growth factor receptor proteins and uses therefor.
AU3563397A (en) Methods for determining the presence of brain protein s-100
CA2366523A1 (en) Method for analyzing the amount of intraabdominal adipose tissue
CA2088354A1 (en) Pancreas-Elastasis-1-Specific Antibody, a Process for Obtaining It and a Test Kit Containing Such Antibodies
EP0245052A3 (en) Detection of inflammation and novel antibodies therefor
ATE143673T1 (de) Testverfahren von glykosylierten proteinen unter verwendung eines antikörpers gerichtet gegen reduzierte glykosylierte n-terminal-aminosäuren
SE8900899D0 (sv) Peptides for diagnostic use
EP0293827A3 (en) Assay for leishmaniasis
IL160597A0 (en) Cellular immunity test with peptides fixed on a solid support
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
WO2001055181A3 (en) Recombinant multivalent malarial vaccines against plasmodium vivax
IL160387A0 (en) Antigen mimotopes and vaccine against cancers
CA2286335A1 (en) Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies
WO2001036587A3 (en) Gene for encoding merozoite surface protein of plasmodium vivax and use thereof
Armstrong et al. Demonstration of bile canaliculi by an immunofluorescent staining technique

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed